Crossmark

Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions

Published Online: 2022-04-11

Published Print: 2022-12

Authors

Ghaffari, Pouyan

Shoaie, Saeed

Nielsen, Lars K.
Funding

Funding for this research was provided by:

Novo Nordisk Fonden (NNF20CC0035580, NNF14OC0009473)

Engineering and Physical Sciences Research Council (EP/S001301/1)

Biotechnology and Biological Sciences Research Council (BB/S016899/1)
License Information

Text and Data Mining valid from 2022-04-11

Version of Record valid from 2022-04-11
More Information

Article History

Received: 6 December 2021

Accepted: 26 March 2022

First Online: 11 April 2022

Declarations

:

: There is no new data generated as part of this review.

: All the authors read the final version and approved it.

: There is no conflict of interest.

Document is current